Our Partners
From Nelson, New Zealand, we leverage the region’s internationally-renowned scientific community and our global networks.
GLOBAL EXPERTISE
Kimer Med has worked with global experts in recombinant protein fabrication and virology from the outset. Outsourcing some of our early research and testing allowed us to reduce risk and progress faster, with lower costs. Since 2020 we have partnered with the following organisations:
PROTEIN FABRICATION:
EFFICACY & TOXICITY TESTING:
CLINICAL TRIAL DESIGN & REGULATORY SUPPORT:
PARTNERING, OUT-LICENSING & STRATEGIC SUPPORT
IN VIVO STUDIES:
PC-2 LAB & GMP FACILITY DESIGN
OUR MISSION:
A family of broad-spectrum antiviral drugs.
The global antiviral drug market is worth US$60 t0 70 billion in annual sales revenue, with growth projected at around 3.8%. Find out more out the opportunity presented by new-to-market broad-spectrum antivirals.